RecruitingNCT05351216
The Effect of Sirolimus on Immunizations During the Treatment of Kaposiform Hemangioendothelioma
Studying Kaposiform hemangioendothelioma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Hospital of Fudan University
- Principal Investigator
- Kai Li, PhD, MSW, LICSWChildren's Hospital of Fudan University
- Enrollment
- 174 target
- Eligibility
- 12 years · All sexes
- Timeline
- 2021 – 2028
Study locations (1)
- Children's Hospital of Fudan University, Shanghai, Shanghai Municipality, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05351216 on ClinicalTrials.govOther trials for Kaposiform hemangioendothelioma
Additional recruiting or active studies for the same condition.